Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04667065
Other study ID # PREPACHIR
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2021
Est. completion date January 1, 2023

Study information

Verified date May 2023
Source Centre Hospitalier Intercommunal Creteil
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a study of a preoperative rehabilitation program with remotely guided high-intensity exercises by physical activity teachers adapted to a smartwatch in patients with operable lung cancer.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date January 1, 2023
Est. primary completion date July 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Major patient, age = 18 - Patient with non-small cell operable bronchial cancer without indication of neo-adjuvant chemotherapy - Affiliated with a social security plan - VEMS < 80% and/or DLCO<80% - High-intensity training achievable for at least 10 days before surgery - Acceptant to participate in the protocol - Ability to follow the STIMUL program of education focused on adapted physical activity - Have a smartphone that can download the mobile app - have the ability to understand, read and write French Exclusion Criteria: - Patient unable to consent: under guardianship or curatorship - Patient refusing surgery - Non-operable patient due to comorbidities or unseable tumour - Poor understanding of the smartwatch - Severe cognitive or psychiatric disorders - Pregnancy in progress

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Physical activity
Physical activity with the remotely guidance of physical activity teachers

Locations

Country Name City State
France Centre hospitalier intercommunal de Créteil Créteil

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Intercommunal Creteil

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measure of VO2 max . comparison of VO2 max at inclusion and one day before surgery 1 day before surgery
Secondary Number of patients who used the remotely guided physical preparation one day before surgery
Secondary maximum distance covered in the 6-minute walking t one day before surgery
Secondary post-surgery complications At 1 month and 3 months
Secondary number of individuals who participated in the physical activity program one day before surgery
Secondary post surgery intubation duration At 1 month
Secondary number of days at hospital At 3 months
Secondary number of days with oxygen At 1 month and 3 months
Secondary (forced expiratory volume At 1 month and 3 months
Secondary capacity of carbon monoxide At 1 month and 3 months
See also
  Status Clinical Trial Phase
Completed NCT03918538 - A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors N/A
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Active, not recruiting NCT04548830 - Safety of Lung Cryobiopsy in People With Cancer Phase 2
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Not yet recruiting NCT06376253 - A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Phase 1
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Active, not recruiting NCT03575793 - A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Phase 1/Phase 2
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Terminated NCT03275688 - NanoSpectrometer Biomarker Discovery and Confirmation Study
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Recruiting NCT06052449 - Assessing Social Determinants of Health to Increase Cancer Screening N/A
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk